Ask AI
ProCE Banner Series

Molecular Residual Disease Testing: A Product and Clinical Data Overview

Molecular Residual Disease (MRD) testing in patients with Colorectal Cancer.

Key Takeaways

  • Incorporating MRD testing into clinical practice for the treatment and surveillance of patients with colorectal cancer
  • Introduction to Exact Sciences' newly available tumor-informed MRD test for patients with solid tumors, Oncodetect(TM).
  • Learn more about the Oncodetect test's clinical data across stages II-IV CRC, featured in the Alpha-CORRECT and Beta-CORRECT clinical studies.

All Events

Molecular Residual Disease Testing: A Product and Clinical Data Overview

Upcoming Events

July

23

2025

12:15 PM - 12:45 PM Eastern Time (ET)

Virtual

Acknowledgement

Sponsored By

Oncodetect